Yang Jin

Yang Jin

Auto-generated profile, based on publicly available information

Yang Jin

Department of Biosciences, University of Oslo, Oslo, Norway

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
XSXia Sheng
Xia Sheng
HNHatice Zeynep Nenseth
Hatice Zeynep Nenseth
SQSu Qu
Su Qu
OKOmer F. Kuzu
Omer F. Kuzu
TFTurid Frahnow
Turid Frahnow
FSFahri Saatcioglu
Fahri Saatcioglu
Activation of endoplasmic reticulum (ER) stress/the unfolded protein response (UPR) has been linked to cancer, but the molecular mechanisms are poorly understood and there is a paucity of reagents to translate this for cancer therapy. Here, we report that an IRE1α RNase-specific inhibitor, MKC8866, strongly inhibits prostate cancer (PCa) tumor growth as monotherapy in multiple preclinical models in mice and shows synergistic antitumor effects with current PCa drugs. Interestingly, global transcriptomic analysis reveal that IRE1α-XBP1s pathway activity is required for c-MYC signaling, one of the most highly activated oncogenic pathways in PCa. XBP1s is necessary for optimal c-MYC mRNA and protein expression, establishing, for the first time, a direct link between UPR and oncogene activation. In addition, an XBP1-specific gene expression signature is strongly associated with PCa prognosis. Our data establish IRE1α-XBP1s signaling as a central pathway in PCa and indicate that its targeting may offer novel treatment strategies.

20 April 2020 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
TZTingting Zhang
Tingting Zhang
NLNingning Li
Ningning Li
CSChaoyang Sun
Chaoyang Sun
YJYang Jin
Yang Jin
XSXia Sheng
Xia Sheng
The transcription factors of the MYC family play pivotal roles in the initiation and progression of human cancers. High oncogenic level of MYC invades low‐affinity sites and enhancer sequences, which subsequently alters the transcriptome, causes metabolic imbalance, and induces stress response. The endoplasmic reticulum (ER) not only plays a central role in maintaining proteostasis, but also contributes to other key biological processes, including Ca 2+ metabolism and the synthesis of lipids and glucose. Stress conditions, such as shortage in glucose or oxygen and disruption of Ca 2+ homeostasis, may perturb proteostasis and induce the unfolded protein response (UPR), which either restores homeostasis or triggers cell death. Crucial roles of ER stress and UPR signaling have been implicated in various cancers, from oncogenesis to treatment response. Here, we summarize the current knowledge on the interaction between MYC and UPR signaling, and its contribution to cancer development. We also discuss the potential of targeting key UPR signaling nodes as novel synthetic lethal strategies in MYC‐driven cancers.

11 April 2015 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
XSXia Sheng
Xia Sheng
YAYke Jildouw Arnoldussen
Yke Jildouw Arnoldussen
MSMargrethe Storm
Margrethe Storm
MTMartina Tesikova
Martina Tesikova
HNHatice Zeynep Nenseth
Hatice Zeynep Nenseth
FSFahri Saatcioglu
Fahri Saatcioglu
The unfolded protein response (UPR) is a homeostatic mechanism to maintain endoplasmic reticulum (ER) function. The UPR is activated by various physiological conditions as well as in disease states, such as cancer. As androgens regulate secretion and development of the normal prostate and drive prostate cancer (PCa) growth, they may affect UPR pathways. Here, we show that the canonical UPR pathways are directly and divergently regulated by androgens in PCa cells, through the androgen receptor (AR), which is critical for PCa survival. AR bound to gene regulatory sites and activated the IRE1α branch, but simultaneously inhibited PERK signaling. Inhibition of the IRE1α arm profoundly reduced PCa cell growth in vitro as well as tumor formation in preclinical models of PCa in vivo . Consistently, AR and UPR gene expression were correlated in human PCa, and spliced XBP‐1 expression was significantly upregulated in cancer compared with normal prostate. These data establish a genetic switch orchestrated by AR that divergently regulates the UPR pathways and suggest that targeting IRE1α signaling may have therapeutic utility in PCa.

13 February 2015 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
YJYang Jin
Yang Jin
LWLing Wang
Ling Wang
SQSu Qu
Su Qu
XSXia Sheng
Xia Sheng
AKAlexandr Kristian
Alexandr Kristian
FSFahri Saatcioglu
Fahri Saatcioglu
The six transmembrane protein of prostate 2 ( STAMP2) is an androgen‐regulated gene whose mRNA expression is increased in prostate cancer (PCa). Here, we show that STAMP2 protein expression is increased in human PCa compared with benign prostate that is also correlated with tumor grade and treatment response. We also show that STAMP2 significantly increased reactive oxygen species (ROS) in PCa cells through its iron reductase activity which also depleted NADPH levels. Knockdown of STAMP2 expression in PCa cells inhibited proliferation, colony formation, and anchorage‐independent growth, and significantly increased apoptosis. Furthermore, STAMP2 effects were, at least in part, mediated by activating transcription factor 4 (ATF4), whose expression is regulated by ROS. Consistent with in vitro findings, silencing STAMP2 significantly inhibited PCa xenograft growth in mice. Finally, therapeutic silencing of STAMP2 by systemically administered nanoliposomal siRNA profoundly inhibited tumor growth in two established preclinical PCa models in mice. These data suggest that STAMP2 is required for PCa progression and thus may serve as a novel therapeutic target.

16 July 2019 in Oncogene
Verified
Journal Article
Closed access
NPNora Pällmann
Nora Pällmann
MLMarte Livgård
Marte Livgård
MTMartina Tesikova
Martina Tesikova
HNHatice Zeynep Nenseth
Hatice Zeynep Nenseth
EAErman Akkus
Erman Akkus
FSFahri Saatcioglu
Fahri Saatcioglu

24 June 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
YJYang Jin
Yang Jin
SQSu Qu
Su Qu
MTMartina Tesikova
Martina Tesikova
LWLing Wang
Ling Wang
AKAlexandr Kristian
Alexandr Kristian
FSFahri Saatcioglu
Fahri Saatcioglu
Significance: All cancer lesions sustain alterations in signaling pathways, which are the drivers of disease initiation and progression. Study of altered signaling in cancer is thus important to develop more effective therapeutic regimens as well as better prognostic markers. In this study, we show that two of the most frequently altered signaling pathways in prostate cancer, the androgen receptor and the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin pathways, are dependent on kallikrein related peptidase 4 (KLK4), whose expression is highly prostate enriched. Our results suggest that KLK4 has a central role in prostate cancer survival and that KLK4 silencing may have significant therapeutic efficacy.